Major advances in diagnostic technologies are offering unprecedented insight into the
condition of the retina and beyond ocular disease. Digital images providing millions of …

Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive
retinal degenerative disease of the macula that affects elderly people and cause central …

Background Faricimab is a bispecific antibody that acts through dual inhibition of both
angiopoietin-2 and vascular endothelial growth factor A. We report primary results of two …

Purpose To test the hypothesis that tolerating some subretinal fluid (SRF) in patients with
neovascular age-related macular degeneration (nAMD) treated with ranibizumab using a …

Purpose To evaluate efficacy and safety of intravitreal injections of aflibercept (IVT-AFL) treat-
and-extend (T&E) dosing regimens in treatment-naïve patients with exudative age-related …

Purpose Two similarly designed phase 3 trials (HAWK and HARRIER) compared
brolucizumab, a single-chain antibody fragment that inhibits vascular endothelial growth …

Retinal swelling due to the accumulation of fluid is associated with the most vision-
threatening retinal diseases. Optical coherence tomography (OCT) is the current standard of …

Deep learning evolves into a new form of machine learning technology that is classified
under artificial intelligence (AI), which has substantial potential for large-scale healthcare …

Retinal fluid as the major biomarker in exudative macular disease is accurately visualized by
high-resolution three-dimensional optical coherence tomography (OCT), which is used …

Purpose: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg
in treatment-naive patients with neovascular age-related macular degeneration enrolled in …